First report of overall survival for ipilimumab plus nivolumab from the phase III Checkmate 067 study in advanced melanoma. (19th January 2018)

Record Type:: Journal Article
Title:: First report of overall survival for ipilimumab plus nivolumab from the phase III Checkmate 067 study in advanced melanoma. (19th January 2018)
Main Title:: First report of overall survival for ipilimumab plus nivolumab from the phase III Checkmate 067 study in advanced melanoma
Authors:: Turajlic, S
Gore, M
Larkin, J
Abstract:
Is Part Of:: Annals of oncology. Volume 29:Number 3(2018)
Journal:: Annals of oncology
Issue:: Volume 29:Number 3(2018)
Issue Display:: Volume 29, Issue 3 (2018)
Year:: 2018
Volume:: 29
Issue:: 3
Issue Sort Value:: 2018-0029-0003-0000
Page Start:: 542
Page End:: 543
Publication Date:: 2018-01-19
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdy020 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12183.xml